tamsulosin has been researched along with indoramin in 6 studies
Studies (tamsulosin) | Trials (tamsulosin) | Recent Studies (post-2010) (tamsulosin) | Studies (indoramin) | Trials (indoramin) | Recent Studies (post-2010) (indoramin) |
---|---|---|---|---|---|
1,460 | 468 | 693 | 237 | 65 | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
Chang, DJ; Clarke, DE; Daniels, DV; Ford, AP; Gever, JR; Jasper, JR; Lesnick, JD | 1 |
Chang, DJ; Clarke, DE; Daniels, DV; Ford, AP; Gever, JR; Jasper, JR; Kava, MS; Lesnick, JD; Meloy, TD; Stepan, G; Williams, TJ | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I | 1 |
Clifford, GM; Farmer, RD | 1 |
3 review(s) available for tamsulosin and indoramin
Article | Year |
---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
[Alpha blockers in the treatment of benign hyperplasia of the prostate].
Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 1997 |
Medical therapy for benign prostatic hyperplasia: a review of the literature.
Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 2000 |
3 other study(ies) available for tamsulosin and indoramin
Article | Year |
---|---|
Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification.
Topics: Adrenergic Agents; Animals; CHO Cells; Cloning, Molecular; Cricetinae; Humans; Inositol Phosphates; Radioligand Assay; Receptors, Adrenergic, alpha-1; Recombinant Proteins | 1997 |
Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies.
Topics: Adrenergic alpha-Agonists; Animals; CHO Cells; Cloning, Organism; Cricetinae; Humans; In Vitro Techniques; Inositol Phosphates; Protein Isoforms; Receptors, Adrenergic, alpha-1; Recombinant Proteins | 1999 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |